AI assistant
Alphamab Oncology — Board/Management Information 2021
Aug 27, 2021
51191_rns_2021-08-27_0de49185-5f27-40f7-86cf-6315fdcd2775.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [172 x 41] intentionally omitted <==
ALPHAMAB ONCOLOGY 康寧傑瑞生物製藥
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 9966)
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
The members of the board of directors (the “ Board ”) of Alphamab Oncology are set out below:
Dr. XU Ting (徐霆)
Ms. LIU Yang (劉陽)
Mr. XU Zhan Kevin (許湛)
Mr. QIU Yu Min (裘育敏)
Dr. GUO Zijian (郭子建)
Mr. WEI Kevin Cheng (蔚成) Mr. WU Dong (吳冬)
(Chairman, Executive Director) (Executive Director) (Non-executive Director) (Non-executive Director) (Independent non-executive Director) (Independent non-executive Director) (Independent non-executive Director)
There are four Board committees. The table below provides membership information of these committees on which each Board member serves.
| Committee Director |
Audit Committee |
Remuneration Committee |
Nomination Committee |
Strategy Committee |
|---|---|---|---|---|
| Dr. XU Ting (徐霆) | Chairman | Member | ||
| Ms. LIU Yang (劉陽) | Member | Chairman | ||
| Mr. XU Zhan Kevin (許湛) | Member | |||
| Mr. QIU Yu Min (裘育敏) | Member | |||
| Dr. GUO Zijian (郭子建) | Member | Member | ||
| Mr. WEI Kevin Cheng (蔚成) | Chairman | Member | ||
| Mr. WU Dong (吳冬) | Member | Chairman | Member |
Hong Kong
August 27, 2021